PureTech Ventures

General contacts
Investor type

VC

Founded

-

AUM

-

Location

United States

Investment Ticket

$1-5 m

Investment Stage

Series B

Region of investment

North America
Investor profile last updated: 05 August, 2020

Profile

PureTech Health (LSE: PRTC) is an advanced biopharmaceutical company developing BIG medicines for dysfunctions of the Brain-Immune-Gut axis. The Company has gained deep insights into the connection between these systems and the resulting role in diseases that have proven resistant to established therapeutic approaches. By harnessing this emerging field of human biology, PureTech Health is developing new categories of medicines with the potential to have great impact on people with serious diseases.





PureTech Health is advancing a rich pipeline of innovative therapies with an unbiased, non-binary, and capital efficient R&D model across its affiliates and its internal labs. PureTech’s affiliates include seven clinical-stage platforms, two products that have been filed with the FDA for review, and several other novel preclinical programs. The PureTech Health pipeline includes ground-breaking platforms and therapeutic candidates that were developed in collaboration with some of the world’s leading experts.

Industry

Biotechnology Healthcare Services Pharmaceuticals Software

Contacts

Name
Title
Email
Social Networks
Upgrade to see contacts
avatar
n7wEo9q8N3fYepLA n7wEo9q8N3fYepLA
n7wEo9q8N3fYepLA
n7wEo9q8N3fYepLA@n7wEo9q8N3fYepLA.com
linkedin twitter
avatar
n7wEo9q8N3fYepLA n7wEo9q8N3fYepLA
n7wEo9q8N3fYepLA
n7wEo9q8N3fYepLA@n7wEo9q8N3fYepLA.com
linkedin twitter
avatar
n7wEo9q8N3fYepLA n7wEo9q8N3fYepLA
n7wEo9q8N3fYepLA
n7wEo9q8N3fYepLA@n7wEo9q8N3fYepLA.com
linkedin twitter
avatar
n7wEo9q8N3fYepLA n7wEo9q8N3fYepLA
n7wEo9q8N3fYepLA
n7wEo9q8N3fYepLA@n7wEo9q8N3fYepLA.com
linkedin twitter
avatar
n7wEo9q8N3fYepLA n7wEo9q8N3fYepLA
n7wEo9q8N3fYepLA
n7wEo9q8N3fYepLA@n7wEo9q8N3fYepLA.com
linkedin twitter
Investment-team contacts for PureTech Ventures — including verified work emails and LinkedIn profiles — are available to Private Equity List subscribers.
Instant access on the web. Plans from $129/month — see pricing.
Contacts sourced from the firm's website and LinkedIn, re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.

FAQs about PureTech Ventures

PureTech Ventures is a venture capital firm. It backs companies at Series B, writing tickets of $1-5 m.
PureTech Ventures is located in United States.
PureTech Ventures was founded in .
PureTech Ventures invests in companies and startups in Biotechnology, Healthcare Services, Pharmaceuticals, Software.
PureTech Ventures invests in companies and startups in North America.
PureTech Ventures invests in companies and startups at Series B.
PureTech Ventures usually invests $1-5 m on average.
PureTech Ventures can be reached through its website puretechhealth.com, its LinkedIn page and its X account. Its general enquiries address is info@puretechhealth.com. Cold-mailing a general inbox rarely reaches a partner, so Private Equity List also lists the investment-team contacts for PureTech Ventures — names, roles, verified work emails and LinkedIn profiles — available on a Pro plan from $129/month (see pricing). Contacts are sourced from the firm's website and LinkedIn and re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.
Yes. Every field on this page — profile, funds, investment criteria, portfolio and investment-team contacts — is available programmatically through the Private Equity List REST API and MCP server, so AI assistants such as Claude and ChatGPT can query PureTech Ventures directly instead of scraping this page. One subscription covers both the web app and machine access — see API & MCP.
Private Equity List re-verifies investor profiles on a rolling cycle, pulling from the firm's own website and LinkedIn rather than a one-off import. This profile was last updated on 05 August, 2020. Something out of date here? Report it — we re-run that firm within 48h and get back to you.